Home LiteratureArticle Details
PMID: 32111936 Published · epublish English Case Reports Clinical Trial Journal Article Research Support, Non-U.S. Gov't

The hemodynamic complexities underlying transient ischemic attacks in early-stage Moyamoya disease: an exploratory CFD study.

Scientific reports ·Vol. 10 ·No. 1 ·2020-00-28 ·页码 3700

Rashad S, Saqr KM, Fujimura M, Niizuma K, Tominaga T

Abstract

Moyamoya disease (MMD) is a rare cerebro-occlusive disease with unknown etiology that can cause both ischemic and hemorrhagic stroke. MMD is characterized by progressive stenosis of the terminal internal carotid artery (ICA) and development of basal brain collaterals. Early-stage MMD is known to cause hemodynamic insufficiency despite mild or moderate stenosis of the intracranial arteries, but the exact mechanism underlying this pathophysiological condition is undetermined. We used high-resolution Large Eddy Simulations to investigate multiple complex hemodynamic phenomena that led to cerebral ischemia in five patients with early-stage MMD. The effects of transitional flow, coherent flow structures and blood shear-thinning properties through regions of tortuous and stenosed arteries were explored and linked to symptomatology. It is evidently shown that in some cases complex vortex structures, such as Rankine-type vortices, redirects blood flow away from some arteries causing significant reduction in blood flow. Moreover, partial blood hammer (PBH) phenomenon was detected in some cases and led to significant hemodynamic insufficiency. PBH events were attributed to the interaction between shear-thinning properties, transitional flow structures and loss of upstream pressure-velocity phase lag. We clearly show that the hemodynamic complexities in early-stage MMD could induce ischemia and explain the non-responsiveness to antiplatelet therapy.

MeSH 主题词
Adolescent Adult Aged Carotid Stenosis/drug therapy,physiopathology Female Hemodynamics Humans Ischemic Attack, Transient/drug therapy,physiopathology Male Middle Aged Moyamoya Disease/drug therapy,physiopathology Platelet Aggregation Inhibitors/administration & dosage
化学物质
Platelet Aggregation Inhibitors
作者与单位
共 5 位作者,点击展开单位 / ORCID
Rashad Sherif ORCID
Department of Neurosurgical Engineering and Translational Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8575, Japan. [email protected]. | Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8575, Japan. [email protected].
Saqr Khalid M ORCID
Mechanical Engineering Department, College of Engineering and Technology, Arab Academy for Science, Technology and Maritime Transport, 1029, Abu-Kir, Alexandria, Egypt.
Fujimura Miki
Department of Neurosurgery, Kohnan hospital, Sendai, Miyagi, Japan. [email protected].
Niizuma Kuniyasu ORCID
Department of Neurosurgical Engineering and Translational Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8575, Japan. | Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8575, Japan. | Department of Neurosurgical Engineering and Translational Neuroscience, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.
Tominaga Teiji
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8575, Japan.
Article Info
Journal
Scientific reports
Abbr.
Sci Rep
ISSN
2045-2322
Published
2020-00-28
电子出版
2020-00-28
页码
3700
Language
English
Country/Region
England
NLM ID
101563288
勘误 / 撤稿关联
ErratumIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]